These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification of ligands with bicyclic scaffolds provides insights into mechanisms of estrogen receptor subtype selectivity. Hsieh RW; Rajan SS; Sharma SK; Guo Y; DeSombre ER; Mrksich M; Greene GL J Biol Chem; 2006 Jun; 281(26):17909-19. PubMed ID: 16648639 [TBL] [Abstract][Full Text] [Related]
3. Discovery of Novel Selective ERα/ERβ Ligands by Multi-pharmacophore Modeling and Virtual Screening. Huang W; Wei W; Yang Y; Zhang T; Shen Z Chem Pharm Bull (Tokyo); 2015; 63(10):780-91. PubMed ID: 26423034 [TBL] [Abstract][Full Text] [Related]
4. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Harrington WR; Sheng S; Barnett DH; Petz LN; Katzenellenbogen JA; Katzenellenbogen BS Mol Cell Endocrinol; 2003 Aug; 206(1-2):13-22. PubMed ID: 12943986 [TBL] [Abstract][Full Text] [Related]
5. A beta-lactamase-dependent Gal4-estrogen receptor beta transactivation assay for the ultra-high throughput screening of estrogen receptor beta agonists in a 3456-well format. Peekhaus NT; Ferrer M; Chang T; Kornienko O; Schneeweis JE; Smith TS; Hoffman I; Mitnaul LJ; Chin J; Fischer PA; Blizzard TA; Birzin ET; Chan W; Inglese J; Strulovici B; Rohrer SP; Schaeffer JM Assay Drug Dev Technol; 2003 Dec; 1(6):789-800. PubMed ID: 15090225 [TBL] [Abstract][Full Text] [Related]
6. Identification of estrogen receptor dimer selective ligands reveals growth-inhibitory effects on cells that co-express ERα and ERβ. Powell E; Shanle E; Brinkman A; Li J; Keles S; Wisinski KB; Huang W; Xu W PLoS One; 2012; 7(2):e30993. PubMed ID: 22347418 [TBL] [Abstract][Full Text] [Related]
7. Generation of stable reporter breast cancer cell lines for the identification of ER subtype selective ligands. Shanle EK; Hawse JR; Xu W Biochem Pharmacol; 2011 Dec; 82(12):1940-9. PubMed ID: 21924251 [TBL] [Abstract][Full Text] [Related]
8. Estrogen Receptors alpha and beta as determinants of gene expression: influence of ligand, dose, and chromatin binding. Chang EC; Charn TH; Park SH; Helferich WG; Komm B; Katzenellenbogen JA; Katzenellenbogen BS Mol Endocrinol; 2008 May; 22(5):1032-43. PubMed ID: 18258689 [TBL] [Abstract][Full Text] [Related]
9. Negative regulation of estrogen signaling by ERβ and RIP140 in ovarian cancer cells. Docquier A; Garcia A; Savatier J; Boulahtouf A; Bonnet S; Bellet V; Busson M; Margeat E; Jalaguier S; Royer C; Balaguer P; Cavaillès V Mol Endocrinol; 2013 Sep; 27(9):1429-41. PubMed ID: 23885094 [TBL] [Abstract][Full Text] [Related]
10. Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract. Cvoro A; Paruthiyil S; Jones JO; Tzagarakis-Foster C; Clegg NJ; Tatomer D; Medina RT; Tagliaferri M; Schaufele F; Scanlan TS; Diamond MI; Cohen I; Leitman DC Endocrinology; 2007 Feb; 148(2):538-47. PubMed ID: 17095596 [TBL] [Abstract][Full Text] [Related]
11. Diarylpropionitrile (DPN) enantiomers: synthesis and evaluation of estrogen receptor β-selective ligands. Carroll VM; Jeyakumar M; Carlson KE; Katzenellenbogen JA J Med Chem; 2012 Jan; 55(1):528-37. PubMed ID: 22122563 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of ligand selectivity using reporter cell lines stably expressing estrogen receptor alpha or beta. Escande A; Pillon A; Servant N; Cravedi JP; Larrea F; Muhn P; Nicolas JC; Cavaillès V; Balaguer P Biochem Pharmacol; 2006 May; 71(10):1459-69. PubMed ID: 16554039 [TBL] [Abstract][Full Text] [Related]
13. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells. Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765 [TBL] [Abstract][Full Text] [Related]
14. ERα and ERβ Homodimers in the Same Cellular Context Regulate Distinct Transcriptomes and Functions. Song D; He H; Indukuri R; Huang Z; Stepanauskaite L; Sinha I; Haldosén LA; Zhao C; Williams C Front Endocrinol (Lausanne); 2022; 13():930227. PubMed ID: 35872983 [TBL] [Abstract][Full Text] [Related]